| Literature DB >> 32923422 |
Jingchun Fan1,2, Ya Gao3,4, Na Zhao1, Runjing Dai1, Hailiang Zhang1, Xiaoyan Feng1, Guoxiu Shi1,5, Jinhui Tian3,4, Che Chen6, Brett D Hambly1,7, Shisan Bao1,7.
Abstract
Background: As an emerging infectious disease, COVID-19 has garnered great research interest. We aimed to explore the differences between English language and Chinese language Medical/Scientific journals publications, particularly aiming to explore the efficacy/contents of the literature published in English and Chinese in relation to the outcomes of management and characterization of COVID-19 during the early stage of COVID-19 pandemic.Entities:
Keywords: COVID-19 outbreaks; Chinese; English; SARS-CoV-2; bibliometric
Year: 2020 PMID: 32923422 PMCID: PMC7456831 DOI: 10.3389/fpubh.2020.00477
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
The top 10 authors and journals of COVID-19 research in English and Chinese [n (%)].
| 1 | Li Y | 7 (4.9) | Wang Y | 6 (0.8) | J Med Virol | 18 (12.6) | Chin General Practice Nursing | 41 (5.7) |
| 2 | Benvenuto D | 5 (3.5) | Yang F | 6 (0.8) | Euro Surveillance | 16 (11.2) | J Trad Chin Med | 23 (3.2) |
| 3 | Eurosurveillance Editorial Team | 5 (3.5) | Wang Y | 5 (0.7) | Lancet | 13 (9.1) | Chin Herb Med | 18 (2.5) |
| 4 | Leung G | 5 (3.5) | Guo Y (1st Affiliated Hosp, Xi'an Jiaotong Uni) | 4 (0.6) | Emerging Microbes Infect | 6 (4.2) | World J Trad Chin Med | 16 (2.2) |
| 5 | Angeletti S | 4 (2.8) | Lei X (2nd Affiliated Hosp, Xi'an Jiaotong Uni) | 4 (0.6) | NEJM. | 6 (4.2) | Herald Med | 15 (2.1) |
| 6 | Gao G | 4 (2.8) | Li S (2nd Affiliated Hosp, Xi'an Jiaotong Uni) | 4 (0.6) | Viruses | 5 (3.5) | Shanghai Med J | 14 (1.9) |
| 7 | Ran J | 4 (2.8) | Luo F (Union West China Hosp, Sichuan Uni) | 4 (0.6) | Radiology | 4 (2.8) | Chin J Tuberc Resp Dis | 13 (1.8) |
| 8 | Wei Y | 4 (2.8) | Miao Q (Xiyuan Hosp, Academy Chinese Med Sci) | 4 (0.6) | World J Pediatric | 4 (2.8) | Chin J Prev Med | 12 (1.7) |
| 9 | Wu J | 4 (2.8) | Shi J (Longhua Hosp, Shanghai Uni TCM | 4 (0.6) | BML | 3 (2.1) | Chongqing Med | 11 (1.5) |
| 10 | Yang G | 4 (2.8) | Shu B (Longhua Hosp, Shanghai Uni TCM) | 4 (0.6) | JAMA | 3 (2.1) | China Trop Med/ Chin J Resp Critical Care Med/Chin Nur Res | 10 (1.4) |
Figure 1The level of cooperation among the identified authors. (A) for English papers; (B) for Chinese papers.
Figure 2(A) The cooperation among the countries (A) and provinces in China (B); The cooperation among the institutions for English (C) and Chinese (D) publications.
The top five countries/areas and institutions that contributed to publications of COVID-19 research in English and Chinese [n (%)].
| 1 | China | 75 (52) | Wuhan University, Hubei | 15 (6) |
| 2 | USA | 34 (24) | University of HongKong | 12 (5) |
| 3 | UK | 11 (8) | Chinese Academy of Sciences | 9 (4) |
| 4 | Canada | 11 (8) | Huazhong Uni Sci Technol, Hubei | 8 (3) |
| 5 | Italy | 10 (7) | Chinese CDC | 6 (2) |
| 1 | Beijing | 168 (23) | Union Hosp, Tongji Med College, Huazhong Uni Sci Technol, Hubei | 37 (5) |
| 2 | Hubei | 136 (19) | Union West China Hosp, Sichuan Uni | 32 (5) |
| 3 | Shanghai | 90 (12) | Tongji Hosp, Tongji Med College, Huazhong Uni Sci Technol, Hubei | 23 (3) |
| 4 | Guangdong | 78 (11) | Beijing Uni Chin Med | 18 (3) |
| 5 | Sichuan | 70 (10) | Zhongnan Hosp, Wuhan Uni, Hubei | 16 (2) |
Figure 3The cluster analysis of English (A) and Chinese (B) keywords.
The top 20 keywords in terms of frequency for COVID-19 research in English and Chinese [n (%)].
| 1 | SARS-CoV-2 | 93 (19.7) | COVID-19 | 543 (44.0) |
| 2 | COVID-19 | 44 (9.3) | SARS-CoV-2 | 381 (30.9) |
| 3 | China | 36 (7.6) | Prevention and control | 141 (11.4) |
| 4 | SARS | 22 (4.8) | Traditional Chinese Medicine | 140 (11.3) |
| 5 | Epidemic | 17 (3.6) | Computed tomography | 35 (2.8) |
| 6 | Adult | 15 (3.2) | Epidemic | 29 (2.4) |
| 7 | Psychological | 15 (3.2) | Public health | 24 (1.9) |
| 8 | Nucleic acids | 12 (2.5) | MERS | 21 (1.7) |
| 9 | Plague | 11 (2.3) | Pneumonia | 21 (1.7) |
| 10 | Infection | 11 (2.3) | Male | 20 (1.6) |
| 11 | Child | 8 (1.7) | Wuhan | 19 (1.6) |
| 12 | Antiviral drugs | 8 (1.7) | Endogenous compound | 18 (1.5) |
| 13 | Nursing | 8 (1.7) | Female | 18 (1.5) |
| 14 | Therapeutics | 6 (1.3) | Phylogeny | 15 (1.5) |
| 15 | Diagnosis | 5 (1.1) | Outbreak | 14 (1.2) |
| 16 | MERS | 5 (1.1) | Communicable disease | 13 (1.1) |
| 17 | Clinical feature | 5 (1.1) | Fever | 13 (1.1) |
| 18 | Nurses | 4 (0.9) | Travel | 13 (1.1) |
| 19 | Amino acid | 4 (0.9) | Traditional Chinese | 13 (1.1) |
| 20 | Angiotensin | 4 (0.9) | Cladistics | 9 (0.9) |